Michael B Atkins

59PUBLICATIONS
278CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jul 22, 2026
Tertiary lymphoid structures harbour stem-like tumour-specific T cells.

|Jul 21, 2026
Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group Trials.

|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.

|Mar 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.

Rana R McKay, Archana Ajmera, Michael B Atkins

|Jan 30, 2026
Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma.

Hollis Viray, Charlene M Mantia, Opeyemi A Jegede

|Jan 09, 2026
Effects of Vemurafenib ± Cobimetinib on Intratumoral and Host Immunity in Patients With BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy.

Suthee Rapisuwon, Craig L Slingluff, Jennifer A Wargo

Pageof 10

Frequent Collaborators

12 joint publications

Toni K Choueiri

9 joint publications

Meredith M Regan

8 joint publications

David Braun

8 joint publications

Paolo Antonio Ascierto